The current generation of NMDA receptor antagonists such as NR2B antagonists, R-ketamine, and combination therapies with ketamine will settle out within the next five to ten years, while increasing exercise to reasonably high levels can be helpful for depression by raising BDNF and synergizing with antidepressant treatment.